Douglas Lane & Associates, LLC Novartis Ag Transaction History

Douglas Lane & Associates, LLC

$6.79 Billion
Q1 2024

A detailed history of Douglas Lane & Associates, LLC transactions in Novartis Ag stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 179,964 shares of NVS stock, worth $19.2 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

179,964

Previous 174,711 3.01%

Holding current value

$19.2 Million

Previous $17.6 Million 1.32%

% of portfolio

0.26%

Previous 0.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$95.27 - $108.47 $500,453 - $569,792	5,253 Added 3.01%	179,964 $17.4 Million
Q4 2023 Jan 17, 2024	SELL	$92.27 - $101.54 $610,550 - $671,890	-6,617 Reduced 3.65%	174,711 $17.6 Million
Q3 2023 Oct 16, 2023	SELL	$94.73 - $105.13 $1.29 Million - $1.43 Million	-13,609 Reduced 6.98%	181,328 $18.5 Million
Q2 2023 Jul 19, 2023	SELL	$92.52 - $104.91 $1.21 Million - $1.37 Million	-13,067 Reduced 6.28%	194,937 $19.7 Million
Q1 2023 Apr 17, 2023	SELL	$80.03 - $92.81 $988,530 - $1.15 Million	-12,352 Reduced 5.61%	208,004 $19.1 Million

Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $31,353 - $38,395	-415 Reduced 0.19%	220,356 $20 Million
Q4 2022 Jan 17, 2023	SELL	$75.55 - $92.52 $6.05 Million - $7.4 Million	-80,035 Reduced 26.61%	220,771 $20 Million
Q3 2022 Oct 14, 2022	SELL	$74.61 - $87.26 $1.86 Million - $2.17 Million	-24,900 Reduced 7.64%	300,806 $22.9 Million
Q2 2022 Jul 18, 2022	SELL	$80.52 - $93.75 $528,050 - $614,812	-6,558 Reduced 1.97%	325,706 $27.5 Million
Q1 2022 Apr 25, 2022	SELL	$80.11 - $90.62 $3.75 Million - $4.24 Million	-46,825 Reduced 12.35%	332,264 $29.2 Million
Q4 2021 Jan 25, 2022	SELL	$79.7 - $88.13 $15.5 Million - $17.1 Million	-194,230 Reduced 33.88%	379,089 $33.2 Million
Q3 2021 Oct 21, 2021	SELL	$81.78 - $95.14 $6.48 Million - $7.54 Million	-79,248 Reduced 12.14%	573,319 $46.9 Million
Q2 2021 Jul 19, 2021	SELL	$85.24 - $94.15 $3.44 Million - $3.8 Million	-40,411 Reduced 5.83%	652,567 $59.5 Million
Q1 2021 Apr 19, 2021	BUY	$83.5 - $98.47 $4.96 Million - $5.85 Million	59,424 Added 9.38%	692,978 $59.2 Million
Q4 2020 Jan 14, 2021	BUY	$78.07 - $94.43 $4.41 Million - $5.33 Million	56,433 Added 9.78%	633,554 $59.8 Million
Q3 2020 Oct 19, 2020	BUY	$82.14 - $91.0 $13.3 Million - $14.8 Million	162,375 Added 39.15%	577,121 $50.2 Million
Q2 2020 Jul 28, 2020	BUY	$80.93 - $91.1 $2.76 Million - $3.11 Million	34,107 Added 8.96%	414,746 $36.2 Million
Q1 2020 Apr 20, 2020	BUY	$70.67 - $99.01 $1.76 Million - $2.47 Million	24,914 Added 7.0%	380,639 $31.4 Million
Q4 2019 Jan 27, 2020	BUY	$84.35 - $95.37 $1.22 Million - $1.38 Million	14,503 Added 4.25%	355,725 $33.7 Million
Q3 2019 Oct 16, 2019	SELL	$85.54 - $94.26 $169,454 - $186,729	-1,981 Reduced 0.58%	341,222 $29.7 Million
Q2 2019 Jul 08, 2019	BUY	$75.4 - $92.8 $875,469 - $1.08 Million	11,611 Added 3.5%	343,203 $31.3 Million
Q1 2019 Apr 23, 2019	BUY	$75.32 - $86.15 $54,682 - $62,544	726 Added 0.22%	331,592 $31.9 Million
Q4 2018 Jan 17, 2019	SELL	$73.66 - $82.02 $384,947 - $428,636	-5,226 Reduced 1.55%	330,866 $28.4 Million
Q3 2018 Oct 09, 2018	SELL	$66.94 - $77.43 $228,533 - $264,346	-3,414 Reduced 1.01%	336,092 $29 Million
Q2 2018 Jul 23, 2018	SELL	$64.91 - $73.36 $1.94 Million - $2.19 Million	-29,899 Reduced 8.09%	339,506 $25.6 Million
Q1 2018 Apr 23, 2018	SELL	$70.39 - $84.15 $545,100 - $651,657	-7,744 Reduced 2.05%	369,405 $29.9 Million
Q4 2017 Jan 24, 2018	SELL	$72.33 - $77.64 $817,184 - $877,176	-11,298 Reduced 2.91%	377,149 $31.7 Million
Q3 2017 Oct 19, 2017	BUY	$74.14 - $77.27 $28.8 Million - $30 Million	388,447	388,447 $33.3 Million

Others Institutions Holding NVS

# of Institutions

1,346

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Account

Douglas Lane & Associates, LLC Novartis Ag Transaction History